[HTML][HTML] Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets

M Bai, S Ke, H Yu, Y Xu, Y Yu, S Lu, C Wang… - Frontiers in …, 2022 - frontiersin.org
Background Thyroid carcinoma (THCA) has a low mortality rate, but its incidence has been
rising over the years. We need to pay attention to its progression and prognosis. In this …

Genomic profiling of aggressive thyroid cancer in association with its clinicopathological characteristics

JH Kim, JY Jeong, AN Seo, NJY Park, M Kim, JY Park - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: Poorly differentiated thyroid carcinoma (PDTC), anaplastic thyroid
carcinoma (ATC), and advanced DTC have poor outcomes. Materials and Methods: We …

[HTML][HTML] MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer

L Dai, Y Wang, L Chen, J Zheng, J Li, X Wu - World journal of surgical …, 2017 - Springer
Background Many studies have reported several transcriptionally deregulated microRNAs
(miRNAs) in papillary thyroid cancer (PTC) tissue in comparison with benign thyroid nodules …

miR-146b is Highly Expressed in Adult Papillary Thyroid Carcinomas with High Risk Features Including Extrathyroidal Invasion and the BRAFV600E Mutation

CK Chou, RF Chen, FF Chou, HW Chang, YJ Chen… - Thyroid, 2010 - liebertpub.com
Background: Papillary thyroid carcinoma (PTC) are clinicopathogenetically heterogeneous.
Micro-RNAs (miRNAs) are involved in the pathogenesis of diverse human cancers …

MicroRNA expression and association with clinicopathologic features in papillary thyroid cancer: a systematic review

P Aragon Han, CH Weng, HT Khawaja, N Nagarajan… - Thyroid, 2015 - liebertpub.com
Background: Studies have suggested that microRNAs (miR) may be useful prognostic
markers and are associated with aggressive clinicopathologic features in papillary thyroid …

[HTML][HTML] Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas

G Gandolfi, M Ragazzi, D de Biase, M Visani… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Background Papillary Thyroid Carcinomas (PTCs) are generally indolent tumors. However,
a small but significant percentage of PTCs behaves aggressively, progressing to a diffuse …

[HTML][HTML] Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction

GJ Xu, MA Loberg, JN Gallant, Q Sheng, SC Chen… - Cell Genomics, 2023 - cell.com
Genomic and transcriptomic analysis has furthered our understanding of many tumors. Yet,
thyroid cancer management is largely guided by staging and histology, with few molecular …

[HTML][HTML] Identification of key genes and miRNAs markers of papillary thyroid cancer

J Qiu, W Zhang, C Zang, X Liu, F Liu, R Ge, Y Sun… - Biological …, 2018 - SciELO Chile
QIU, Jie et al. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Biol. Res.[online]. 2018, vol. 51, 45. Epub 28-Nov-2018. ISSN 0716-9760. http://dx. doi …

[HTML][HTML] Potential five‑mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma

LK Zhong, XX Gan, XY Deng, F Shen… - Oncology …, 2020 - spandidos-publications.com
Although the mortality rate of papillary thyroid carcinoma (PTC) is relatively low, the
recurrence rates of PTC remain high. The high recurrence rates are related to the difficulties …

Prognostic value of a two‐microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions

T Liu, X You, J Sui, B Shen, Y Zhang… - Journal of cellular …, 2019 - Wiley Online Library
Background Recent scientific evidence has suggested that microRNAs (miRNAs) play an
important role in papillary thyroid cancer (PTC). In the current study, we aim to identify a …